Agilent Technologies, Inc. $A Holdings Raised by Calamos Advisors LLC

Calamos Advisors LLC raised its position in Agilent Technologies, Inc. (NYSE:A) by 2.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 163,901 shares of the medical research company’s stock after purchasing an additional 3,316 shares during the quarter. Calamos Advisors LLC owned about 0.06% of Agilent Technologies worth $28,242,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in A. Bank of Nova Scotia purchased a new position in shares of Agilent Technologies in the second quarter valued at approximately $58,539,000. Dudley & Shanley Inc. increased its stake in Agilent Technologies by 25.9% during the 2nd quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock worth $9,232,000 after buying an additional 14,300 shares during the period. BIP Wealth LLC purchased a new stake in Agilent Technologies during the 2nd quarter worth approximately $834,000. Sivia Capital Partners LLC acquired a new stake in Agilent Technologies during the 2nd quarter worth approximately $1,818,000. Finally, KBC Group NV lifted its holdings in Agilent Technologies by 18.4% during the 2nd quarter. KBC Group NV now owns 81,883 shares of the medical research company’s stock worth $10,877,000 after buying an additional 12,719 shares in the last quarter.

Agilent Technologies Stock Performance

NYSE:A traded up $3.01 during trading hours on Friday, reaching $174.79. 2,048,423 shares of the company’s stock were exchanged, compared to its average volume of 2,094,801. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $182.99. The company has a 50-day moving average of $165.94 and a 200 day moving average of $137.20. The firm has a market capitalization of $49.28 billion, a price-to-earnings ratio of 34.41, a P/E/G ratio of 2.52 and a beta of 1.24.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The firm had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. During the same period in the prior year, the business earned $1.37 EPS. The firm’s revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts anticipate that Agilent Technologies, Inc. will post 6.20 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 28th. Shareholders of record on Tuesday, October 6th were given a dividend of $0.2550 per share. The ex-dividend date was Tuesday, October 6th. This represents a $1.02 annualized dividend and a yield of 0.6%. Agilent Technologies’s payout ratio is presently 20.08%.

Insider Activity

In other news, Director Mikael Dolsten sold 634 shares of the firm’s stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the sale, the director directly owned 4,924 shares of the company’s stock, valued at $745,395.12. This trade represents a 11.41% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on A shares. Royal Bank Of Canada boosted their price target on shares of Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a research note on Thursday, August 27th. HSBC increased their price objective on Agilent Technologies from $165.00 to $175.00 and gave the company a “buy” rating in a research note on Tuesday, September 1st. Citigroup lifted their target price on Agilent Technologies from $185.00 to $190.00 and gave the company a “buy” rating in a report on Thursday, August 27th. Bank of America boosted their target price on Agilent Technologies from $180.00 to $190.00 in a research note on Friday, October 9th. Finally, TD Cowen upped their price target on Agilent Technologies from $180.00 to $196.00 and gave the stock a “buy” rating in a report on Tuesday, October 13th. Eighteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $181.45.

Agilent Technologies Profile

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research.

The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Agilent became an independent company in 1999 through a spin-off from Hewlett-Packard.